Cargando…
Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056661/ https://www.ncbi.nlm.nih.gov/pubmed/36986891 http://dx.doi.org/10.3390/pharmaceutics15030994 |
| _version_ | 1785016178351013888 |
|---|---|
| author | Mansour, Amira Mahmoud, Mohamed Y. Bakr, Alaa F. Ghoniem, Monira G. Adam, Fatima A. El-Sherbiny, Ibrahim M. |
| author_facet | Mansour, Amira Mahmoud, Mohamed Y. Bakr, Alaa F. Ghoniem, Monira G. Adam, Fatima A. El-Sherbiny, Ibrahim M. |
| author_sort | Mansour, Amira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10056661 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100566612023-03-30 Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668 Mansour, Amira Mahmoud, Mohamed Y. Bakr, Alaa F. Ghoniem, Monira G. Adam, Fatima A. El-Sherbiny, Ibrahim M. Pharmaceutics Correction MDPI 2023-03-20 /pmc/articles/PMC10056661/ /pubmed/36986891 http://dx.doi.org/10.3390/pharmaceutics15030994 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Mansour, Amira Mahmoud, Mohamed Y. Bakr, Alaa F. Ghoniem, Monira G. Adam, Fatima A. El-Sherbiny, Ibrahim M. Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668 |
| title | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668 |
| title_full | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668 |
| title_fullStr | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668 |
| title_full_unstemmed | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668 |
| title_short | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668 |
| title_sort | correction: mansour et al. dual-enhanced pluronic nanoformulated methotrexate-based treatment approach for breast cancer: development and evaluation of in vitro and in vivo efficiency. pharmaceutics 2022, 14, 2668 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056661/ https://www.ncbi.nlm.nih.gov/pubmed/36986891 http://dx.doi.org/10.3390/pharmaceutics15030994 |
| work_keys_str_mv | AT mansouramira correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencypharmaceutics2022142668 AT mahmoudmohamedy correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencypharmaceutics2022142668 AT bakralaaf correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencypharmaceutics2022142668 AT ghoniemmonirag correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencypharmaceutics2022142668 AT adamfatimaa correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencypharmaceutics2022142668 AT elsherbinyibrahimm correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencypharmaceutics2022142668 |